여성에서의 건선: 관리와 치료

초록

Psoriasis is a chronic inflammatory skin disease affecting 0.5~3% of the general population worldwide. About 50% of these patients are women and the majority of them have onset of disease before 40 years of age, coinciding with the reproductive years. The burden of psoriasis is particularly high for women in all domains of quality of life, which poses specific challenges for their treatment. However, well-established guidelines for the treatment of women of childbearing age are lacking. Because of immunomodulatory change in pregnancy, psoriasis activity often improves or stabilizes during pregnancy. But up to a quarter can experience disease worsening, and postpartum flares are common. Therefore, balancing the risk of treatment with the risk of uncontrolled disease is important. In this article, we review issues specific to treating women of childbearing age with psoriasis and recent guidelines for the treatment of psoriasis in women.

키워드